Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
This study has been completed.
Study NCT00032045   Information provided by National Cancer Institute (NCI)
First Received: March 8, 2002   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Intraocular Melanoma
Melanoma (Skin)
Additional conditions recognized in this trial
Eye Neoplasms
Melanoma
More general conditions related to this trial
Eye Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
gp100 antigen
incomplete Freund's adjuvant
ipilimumab
Additional drug interventions recognized in this trial
Freund's Adjuvant
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services